ReadyCell is a biotechnological company focused on providing sophisticated in vitro tools and R&D services for the ADME-Tox segment.
Our tools are innovative cell-based and ready-to-use kits for efficacy and safety testing of active molecules as an alternative to animal testing, on drug discovery.
The current product portfolio covers a a wide spectrum of drug discovery applications for in vitro screening, including adsorption, metabolism and toxicity assays.
Human hepatocytes in Ready-to-Use Format Cultured human hepatocytes are considered up to date the gold standard model to anticipate in vivo metabolic pathways of drugs and new chemical entities. They represent an accepted in vitro model by the FDA for ADME-Tox...